Citation 1:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%20Total%20revenue%20,year%20period
    Location: chars 782–951

Citation 2:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=fourth%20quarter%20of%202024,with%20FDA%20approval
    Location: chars 1045–1201

Citation 3:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%20Total%20revenue%20,year%20period
    Location: chars 1273–1442

Citation 4:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=year,year
    Location: chars 1520–1660

Citation 5:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%20SG%26A%20expenses%20,mainly%20due%20to%20operating%20losses
    Location: chars 1721–1917

Citation 6:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%202025%20revenue%20guidance%20,is%20included%20in%20current%20guidance
    Location: chars 1981–2186

Citation 7:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=Moderna%20has%20reduced%20its%202025,This%20announcement
    Location: chars 2220–2452

Citation 8:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Submitted%20three%20investigational%20mRNA%20products,59%2C%20and%20flu%2FCOVID%20combination%20vaccine
    Location: chars 2651–2959

Citation 9:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=Australia%2C%20Taiwan%2C%20the%20U,term%20PDUFA
    Location: chars 2960–3138

Citation 10:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=The%20team%20has%20worked%20hard,work%20on%20opex%2C%20capex%2C%20and
    Location: chars 3251–3426

Citation 11:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=To%20manage%20costs%2C%20Moderna%20plans,products%20for%20growth%2C%20including%20a
    Location: chars 3480–3739

Citation 12:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=COVID,1%20billion
    Location: chars 3912–4134

Citation 13:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=RSV%3A%20The%20Company%20reported%20%2415,Arab%20Emirates%2C%20Qatar%20and%20Taiwan
    Location: chars 4183–4471

Citation 14:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=,5%20billion
    Location: chars 4624–4767

Citation 15:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=COVID,1%20billion
    Location: chars 5386–5608

Citation 16:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=COVID,1%20billion
    Location: chars 5655–5877

Citation 17:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=RSV%3A%20The%20Company%20reported%20%2415,Arab%20Emirates%2C%20Qatar%20and%20Taiwan
    Location: chars 5959–6247

Citation 18:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=Jamey%20will%20present%20our%20financial,2%20billion
    Location: chars 6347–6505

Citation 19:
    Title: Moderna 2024 Shareholder Letter
    URL: https://www.modernatx.com/media-center/all-media/blogs/moderna-2024-shareholder-letter#:~:text=Our%20success%20in%20research%20and,ascribed%20to%20our%20broader%20pipeline
    Location: chars 6827–7021

Citation 20:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=Australia%2C%20Taiwan%2C%20the%20U,term%20PDUFA
    Location: chars 7645–7823

Citation 21:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=The%20team%20has%20worked%20hard,our%20focus%20on%2010%20high
    Location: chars 8083–8250

Citation 22:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=To%20manage%20costs%2C%20Moderna%20plans,products%20for%20growth%2C%20including%20a
    Location: chars 8251–8510

Citation 23:
    Title: Moderna 2024 Shareholder Letter
    URL: https://www.modernatx.com/media-center/all-media/blogs/moderna-2024-shareholder-letter#:~:text=Our%20success%20in%20research%20and,ascribed%20to%20our%20broader%20pipeline
    Location: chars 9307–9501

Citation 24:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Submitted%20three%20investigational%20mRNA%20products,59%2C%20and%20flu%2FCOVID%20combination%20vaccine
    Location: chars 9646–9954

Citation 25:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=Australia%2C%20Taiwan%2C%20the%20U,term%20PDUFA
    Location: chars 9955–10133

Citation 26:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=The%20team%20has%20worked%20hard,5%20billion%20of%20cash%20and
    Location: chars 10181–10349

Citation 27:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=The%20team%20has%20worked%20hard,our%20focus%20on%2010%20high
    Location: chars 10468–10635

Citation 28:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=To%20manage%20costs%2C%20Moderna%20plans,products%20for%20growth%2C%20including%20a
    Location: chars 10900–11159

Citation 29:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=COVID,1%20billion
    Location: chars 11467–11689

Citation 30:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=RSV%3A%20The%20Company%20reported%20%2415,Arab%20Emirates%2C%20Qatar%20and%20Taiwan
    Location: chars 11755–12043

Citation 31:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%202025%20revenue%20guidance%20,is%20included%20in%20current%20guidance
    Location: chars 12104–12309

Citation 32:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=Moderna%20has%20reduced%20its%202025,This%20announcement
    Location: chars 12332–12564

Citation 33:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=,5%20billion
    Location: chars 12623–12766

Citation 34:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Reports%20full,28
    Location: chars 12915–13137

Citation 35:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Research%20and%20Development%20Expenses%3A%20The,8%20billion%20in%202023
    Location: chars 13199–13476

Citation 36:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=revenue%20expectations%20to%20a%20range,efficacy%20targets%20in%20the%20study
    Location: chars 13598–13806

Citation 37:
    Title: Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
    URL: https://www.reuters.com/legal/government/pfizer-convinces-us-patent-office-cancel-two-moderna-covid-19-vaccine-patents-2025-03-05/#:~:text=Pfizer%20and%20BioNTech%20scored%20a,Moderna%20filed%20for%20the%20patents
    Location: chars 13907–14141

Citation 38:
    Title: Moderna 2024 Shareholder Letter
    URL: https://www.modernatx.com/media-center/all-media/blogs/moderna-2024-shareholder-letter#:~:text=Our%20success%20in%20research%20and,ascribed%20to%20our%20broader%20pipeline
    Location: chars 14506–14700

Citation 39:
    Title: Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
    URL: https://www.reuters.com/legal/government/pfizer-convinces-us-patent-office-cancel-two-moderna-covid-19-vaccine-patents-2025-03-05/#:~:text=Pfizer%20and%20BioNTech%20scored%20a,Moderna%20filed%20for%20the%20patents
    Location: chars 14811–15045

Citation 40:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=Jamey%20will%20present%20our%20financial,2%20billion
    Location: chars 15991–16149

Citation 41:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Reports%20full,28
    Location: chars 16192–16414

Citation 42:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%20Product%20sales%20,reflecting%20ongoing%20cost%20reduction%20efforts
    Location: chars 17898–18103

Citation 43:
    Title: Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
    URL: https://www.reuters.com/legal/government/pfizer-convinces-us-patent-office-cancel-two-moderna-covid-19-vaccine-patents-2025-03-05/#:~:text=Pfizer%20and%20BioNTech%20scored%20a,Moderna%20filed%20for%20the%20patents
    Location: chars 18261–18495

Citation 44:
    Title: Moderna Inc ESG Rating | KnowESG | KnowESG
    URL: https://www.knowesg.com/esg-ratings/moderna-inc#:~:text=Moderna%2C%20Inc,on%20therapeutic%20areas%20such%20as
    Location: chars 18993–19123

Citation 45:
    Title: Moderna (MRNA) Q4 2024 Earnings Call Transcript | Nasdaq
    URL: https://www.nasdaq.com/articles/moderna-mrna-q4-2024-earnings-call-transcript#:~:text=The%20team%20has%20worked%20hard,5%20billion%20of%20cash%20and
    Location: chars 19303–19471

Citation 46:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=To%20manage%20costs%2C%20Moderna%20plans,products%20for%20growth%2C%20including%20a
    Location: chars 19847–20106

Citation 47:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Full%20Year%202023%20Financial%20Results
    Location: chars 21569–21814

Citation 48:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Reports%20full,28
    Location: chars 21815–22037

Citation 49:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=to%20a%20net%20income%20of,4%20billion%20in%202022
    Location: chars 22048–22303

Citation 50:
    Title: Moderna Inc ESG Rating | KnowESG | KnowESG
    URL: https://www.knowesg.com/esg-ratings/moderna-inc#:~:text=Moderna%2C%20Inc,on%20therapeutic%20areas%20such%20as
    Location: chars 22504–22634

Citation 51:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Full%20Year%202023%20Financial%20Results
    Location: chars 24693–24938

Citation 52:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2025/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Reports%20full,28
    Location: chars 24939–25161

Citation 53:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=%2A%20Total%20revenue%20,year%20period
    Location: chars 25197–25366

Citation 54:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=year,year
    Location: chars 25367–25507

Citation 55:
    Title: Moderna (MRNA) Q1 2025 Earnings Call Transcript | The Motley Fool
    URL: https://www.fool.com/earnings/call-transcripts/2025/12/11/moderna-mrna-q1-2025-earnings-call-transcript/#:~:text=Australia%2C%20Taiwan%2C%20the%20U,term%20PDUFA
    Location: chars 25508–25686

Citation 56:
    Title: Moderna cuts 2025 sales forecast by $1 bln on weak vaccine demand, shares fall
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cuts-2025-sales-view-slow-start-rsv-shot-weak-covid-vaccine-demand-2025-01-13/#:~:text=Moderna%20has%20reduced%20its%202025,This%20announcement
    Location: chars 25739–25971

Citation 57:
    Title: Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
    URL: https://www.reuters.com/legal/government/pfizer-convinces-us-patent-office-cancel-two-moderna-covid-19-vaccine-patents-2025-03-05/#:~:text=Pfizer%20and%20BioNTech%20scored%20a,Moderna%20filed%20for%20the%20patents
    Location: chars 25972–26206

Citation 58:
    Title: Moderna 2024 Shareholder Letter
    URL: https://www.modernatx.com/media-center/all-media/blogs/moderna-2024-shareholder-letter#:~:text=Our%20success%20in%20research%20and,ascribed%20to%20our%20broader%20pipeline
    Location: chars 26235–26429

Citation 59:
    Title: Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
    URL: https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Fourth-Quarter-and-Fiscal-Year-2023-Financial-Results-and-Provides-Business-Updates/default.aspx#:~:text=Research%20and%20Development%20Expenses%3A%20The,8%20billion%20in%202023
    Location: chars 26430–26707

Citation 60:
    Title: Moderna Inc ESG Rating | KnowESG | KnowESG
    URL: https://www.knowesg.com/esg-ratings/moderna-inc#:~:text=Moderna%2C%20Inc,on%20therapeutic%20areas%20such%20as
    Location: chars 26733–26863

